Moderna, Inc. (MUN:0QF)
Germany
· Delayed Price · Currency is EUR 45.60
+3.07 (7.23%)
At close: Mar 5, 2026
Moderna Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 2,595 | 1,927 | 2,907 | 3,205 | 6,848 | Upgrade
|
| Short-Term Investments | 3,204 | 5,098 | 5,697 | 6,697 | 3,879 | Upgrade
|
| Cash & Short-Term Investments | 5,799 | 7,025 | 8,604 | 9,902 | 10,727 | Upgrade
|
| Cash Growth | -17.45% | -18.35% | -13.11% | -7.69% | 132.79% | Upgrade
|
| Accounts Receivable | 184 | 358 | 892 | 1,385 | 3,175 | Upgrade
|
| Other Receivables | 100 | 234 | 189 | 264 | 148 | Upgrade
|
| Receivables | 284 | 592 | 1,081 | 1,685 | 3,323 | Upgrade
|
| Inventory | 153 | 117 | 202 | 1,168 | 1,728 | Upgrade
|
| Prepaid Expenses | 169 | 173 | 182 | 254 | 126 | Upgrade
|
| Other Current Assets | 139 | 192 | 256 | 422 | 167 | Upgrade
|
| Total Current Assets | 6,544 | 8,099 | 10,325 | 13,431 | 16,071 | Upgrade
|
| Property, Plant & Equipment | 2,853 | 2,955 | 2,658 | 2,139 | 1,383 | Upgrade
|
| Long-Term Investments | 2,342 | 2,508 | 4,743 | 8,360 | 6,843 | Upgrade
|
| Goodwill | 52 | 52 | 52 | - | - | Upgrade
|
| Other Intangible Assets | 45 | 40 | 44 | - | - | Upgrade
|
| Long-Term Deferred Tax Assets | 81 | 81 | - | 982 | 326 | Upgrade
|
| Other Long-Term Assets | 421 | 407 | 604 | 946 | 46 | Upgrade
|
| Total Assets | 12,338 | 14,142 | 18,426 | 25,858 | 24,669 | Upgrade
|
| Accounts Payable | 317 | 405 | 520 | 487 | 302 | Upgrade
|
| Accrued Expenses | 827 | 898 | 1,069 | 1,828 | 1,472 | Upgrade
|
| Current Portion of Leases | 42 | 37 | 25 | 196 | 211 | Upgrade
|
| Current Income Taxes Payable | - | - | - | 48 | 876 | Upgrade
|
| Current Unearned Revenue | 99 | 153 | 568 | 2,038 | 6,253 | Upgrade
|
| Other Current Liabilities | 702 | 713 | 833 | 326 | 14 | Upgrade
|
| Total Current Liabilities | 1,987 | 2,206 | 3,015 | 4,923 | 9,128 | Upgrade
|
| Long-Term Debt | 590 | - | - | - | - | Upgrade
|
| Long-Term Leases | 673 | 710 | 1,218 | 1,004 | 705 | Upgrade
|
| Long-Term Unearned Revenue | 153 | 58 | 83 | 673 | 615 | Upgrade
|
| Other Long-Term Liabilities | 285 | 267 | 256 | 135 | 76 | Upgrade
|
| Total Liabilities | 3,688 | 3,241 | 4,572 | 6,735 | 10,524 | Upgrade
|
| Additional Paid-In Capital | 1,382 | 866 | 371 | 1,173 | 4,211 | Upgrade
|
| Retained Earnings | 7,223 | 10,045 | 13,606 | 18,320 | 9,958 | Upgrade
|
| Comprehensive Income & Other | 45 | -10 | -123 | -370 | -24 | Upgrade
|
| Total Common Equity | 8,650 | 10,901 | 13,854 | 19,123 | 14,145 | Upgrade
|
| Shareholders' Equity | 8,650 | 10,901 | 13,854 | 19,123 | 14,145 | Upgrade
|
| Total Liabilities & Equity | 12,338 | 14,142 | 18,426 | 25,858 | 24,669 | Upgrade
|
| Total Debt | 1,305 | 747 | 1,243 | 1,200 | 916 | Upgrade
|
| Net Cash (Debt) | 6,830 | 8,772 | 12,038 | 17,020 | 16,654 | Upgrade
|
| Net Cash Growth | -22.14% | -27.13% | -29.27% | 2.20% | 232.41% | Upgrade
|
| Net Cash Per Share | 17.56 | 22.84 | 31.51 | 40.91 | 38.64 | Upgrade
|
| Filing Date Shares Outstanding | 394.94 | 385.82 | 382.07 | 386.34 | 402.87 | Upgrade
|
| Total Common Shares Outstanding | 394 | 386 | 382 | 385 | 403 | Upgrade
|
| Working Capital | 4,557 | 5,893 | 7,310 | 8,508 | 6,943 | Upgrade
|
| Book Value Per Share | 21.95 | 28.24 | 36.27 | 49.67 | 35.10 | Upgrade
|
| Tangible Book Value | 8,553 | 10,809 | 13,758 | 19,123 | 14,145 | Upgrade
|
| Tangible Book Value Per Share | 21.71 | 28.00 | 36.02 | 49.67 | 35.10 | Upgrade
|
| Land | 78 | 59 | 22 | 11 | - | Upgrade
|
| Buildings | 1,183 | 743 | - | - | - | Upgrade
|
| Machinery | 777 | 525 | 445 | 343 | 211 | Upgrade
|
| Construction In Progress | 298 | 1,057 | 860 | 281 | 212 | Upgrade
|
| Leasehold Improvements | 403 | 207 | 522 | 460 | 313 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.